Skip to main content
SearchLogin or Signup

Reviews of "The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal"

Reviewers: Gaétan de Rassenfosse (Harvard) | 📗📗📗📗◻️ • Keith Maskus (UC Berkeley) | 📒📒📒◻️◻️

Published onJul 05, 2021
Reviews of "The COVID-19 Vaccine Patent Waiver: The Wrong Tool for the Right Goal"

To read the original manuscript, click the link above.

Summary of Reviews: Reviewers find this a well-written opinion piece on the limitations of patent waivers to increase global vaccine coverage; however, they find that this piece would benefit from more empirical references and a more substantial discussion of possible policy and market alternatives.

Reviewer 1 (Gaétan de Rassenfosse) | 📗📗📗📗◻️

Reviewer 2 (Keith Maskus) | 📒📒📒 ◻️◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below.

Comments
0
comment

No comments here